Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. حسب Hyung Suk Yang (20442438)

الموضوعات:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. حسب Richard Junior Zapata Dongo (17912565)

Analysis of Significantly Different Bacteria. حسب Xu Jia (187142)

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. حسب Hyung Suk Yang (20442438)

الموضوعات:

Analysis of Significantly Different ARGs and Resistance Mechanisms. حسب Xu Jia (187142)

Balance test results. حسب Le Zhu (1771669)

الموضوعات:

Variables. حسب Le Zhu (1771669)

الموضوعات:

Results of the parallel trend test. حسب Le Zhu (1771669)

الموضوعات:

Results of the exclusion of other policies. حسب Le Zhu (1771669)

الموضوعات:

Results of robustness tests. حسب Le Zhu (1771669)

الموضوعات:

Descriptive statistical of variables. حسب Le Zhu (1771669)

الموضوعات:

Baseline regression results. حسب Le Zhu (1771669)

الموضوعات:

The results of mediating mechanism test. حسب Le Zhu (1771669)

الموضوعات:

The results of Bootstrap Method and Sobel Test. حسب Le Zhu (1771669)

الموضوعات:

Impact of the NAMR on CSR dimensions (E, S, G). حسب Le Zhu (1771669)

الموضوعات:

Sobel test for the significance of the mediation effect. حسب Getachew Magnar Kitila (19935139)

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

"…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …"

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)